CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 12 of 48

Rheumatology (Oxford)

Briefs 441–480 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Mechanical stress promotes synovial inflammation and osteoarthritis development via the NF-κB p52/IL-6 signalling pathway

    Mechanistic studyOsteoarthritis

  2. Rheumatology (Oxford)

    Real-world data on treatment persistence and measures to minimize cardiovascular risk in rheumatic patients using upadacitinib

    Cohort studyRA

  3. Rheumatology (Oxford)

    Responsiveness of spondyloarthritis-specific health utilities based on the ASAS Health Index (U-ASAS-HI): an ancillary analysis from the ASAS-HI validation study

    Secondary analysisSpondyloarthritis & PsA

  4. Rheumatology (Oxford)

    Coronary artery disease in Behçet’s syndrome: a coronary computed tomography angiography study

    Cross-sectional studyVasculitis & PMR

  5. Rheumatology (Oxford)

    Deprivation indices and their association with fragility fractures and bone density: evidence from a large observational cohort

    Cohort studyOsteoporosis

  6. Rheumatology (Oxford)

    IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies

    Cohort studyPediatric

  7. Rheumatology (Oxford)

    Psoriatic arthritis risk in psoriasis patients receiving anti-IL-23 vs anti-IL-17: comparison of drug classes and individual agents

    Cohort studySpondyloarthritis & PsA

  8. Rheumatology (Oxford)

    Exploring the genetic interaction between ERAP1 / ERAP2 and HLA-B*52:01 in Takayasu arteritis

    Meta-analysisVasculitis & PMR

  9. Rheumatology (Oxford)

    Soluble BDCA-2 as a potential biomarker for rheumatoid arthritis and its role in enhancing IFN-α production through nucleic acid binding

    Mechanistic studyRA

  10. Rheumatology (Oxford)

    Effects of sodium-glucose transporter 2 inhibitors in patients with lupus nephritis: a before-and-after retrospective cohort study

    Cohort studyLupus & APS

  11. Rheumatology (Oxford)

    Anterior mediastinal lesions in TAFRO syndrome: potential clinical significance

    Cohort studyAutoinflammatory & rare

  12. Rheumatology (Oxford)

    Cross-cultural adaptation and preliminary diagnostic performance assessment of the psoriasis epidemiology screening tool (PEST) questionnaire in Spanish

    Diagnostic or prognostic studySpondyloarthritis & PsA

  13. Rheumatology (Oxford)

    Differences in immunogenicity to zoster recombinant vaccine in IMID patients undergoing treatment with non-selective or selective JAK-i

    Cohort studyAcross diseases

  14. Rheumatology (Oxford)

    Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study

    Randomized controlled trialLupus & APS

  15. Rheumatology (Oxford)

    Long-term renal outcomes, cardiovascular events and severe infections in patients with lupus nephritis: MassiLUP cohort 2001–2022

    Cohort studyLupus & APS

  16. Rheumatology (Oxford)

    Association of diastolic dysfunction with myocardial tissue characteristics assessed by multi-parameter cardiac magnetic resonance in patients with idiopathic inflammatory myopathy

    Cross-sectional studyMyositis

  17. Rheumatology (Oxford)

    The risk of cardiovascular events following treatment for PsA with a biological agent

    Cohort studySpondyloarthritis & PsA

  18. Rheumatology (Oxford)

    Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  19. Rheumatology (Oxford)

    Tubulointerstitial inflammation driving interstitial fibrosis and tubular atrophy predicts poor renal outcome in refractory lupus nephritis

    Cohort studyLupus & APS

  20. Rheumatology (Oxford)

    Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-up

    Cohort studyRA

  21. Rheumatology (Oxford)

    Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry

    Cohort studyAutoinflammatory & rare

  22. Rheumatology (Oxford)

    Validation of Boolean 2.0 criteria for remission and quality of life prediction in Korean patients with rheumatoid arthritis receiving targeted therapy

    Cohort studyRA

  23. Rheumatology (Oxford)

    Disease activity and mental health symptoms in axial spondyloarthritis: concordant or discordant?

    Secondary analysisSpondyloarthritis & PsA

  24. Rheumatology (Oxford)

    Cartilage turnover, but not novel synovial collagen marker, is associated with joint damage progression in osteoarthritis patients

    Cohort studyOsteoarthritis

  25. Rheumatology (Oxford)

    Global patterns and determinants of diagnostic delay in spondyloarthritis: insights from the ASAS-PerSpA international study

    Cross-sectional studySpondyloarthritis & PsA

  26. Rheumatology (Oxford)

    High prevalent early damage independently predicts future mortality in an inception cohort of Takayasu arteritis

    Cohort studyVasculitis & PMR

  27. Rheumatology (Oxford)

    PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies

    Cross-sectional studyMyositis

  28. Rheumatology (Oxford)

    Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

    Cohort studyLupus & APS

  29. Rheumatology (Oxford)

    Phenotypic clusters of patients with Takayasu arteritis predict disease activity at presentation, damage and future vascular complications

    Research articleVasculitis & PMR

  30. Rheumatology (Oxford)

    Impact of non-serious infections on medication interruptions, quality of life, and disease flares in patients with rheumatoid arthritis

    Cohort studyRA

  31. Rheumatology (Oxford)

    Modified lung ultrasound score to assess extent and prognosis in systemic autoimmune rheumatic disease-associated interstitial lung disease

    Diagnostic or prognostic studyAcross diseases

  32. Rheumatology (Oxford)

    Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years

    Secondary analysisSpondyloarthritis & PsA

  33. Rheumatology (Oxford)

    Association of SSc with risk of premature ovarian insufficiency: a retrospective cohort study

    Cohort studySystemic sclerosis

  34. Rheumatology (Oxford)

    Differences in spinal structural lesions between patients with early axSpA and non-axSpA chronic back pain: 2-year SPACE cohort results

    Cohort studySpondyloarthritis & PsA

  35. Rheumatology (Oxford)

    SIRT3 inhibits fibroblast-like synoviocytes activation in rheumatoid arthritis through delactylation of H3K18

    Mechanistic studyRA

  36. Rheumatology (Oxford)

    Methylprednisolone plus MTX-based regime vs prednisone-based standard of care for GCA: a propensity score study

    Cohort studyVasculitis & PMR

  37. Rheumatology (Oxford)

    Hydroxychloroquine discontinuation in SLE: a retrospective cohort study with 3-year follow-up

    Cohort studyLupus & APS

  38. Rheumatology (Oxford)

    N-formyl methionine peptide-driven neutrophil activation in idiopathic inflammatory myopathies

    Mechanistic studyMyositis

  39. Rheumatology (Oxford)

    Elevated pre-eclampsia risk in lupus nephritis and antiphospholipid syndrome: a nationwide Spanish registry analysis

    Cohort studyLupus & APS

  40. Rheumatology (Oxford)

    Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis

    Secondary analysisSpondyloarthritis & PsA

All 1,905 Briefs in ExploreShowing Briefs 441–480 of 1,905, newest first